ing.251
Screening for AAA in women is more controversial.
Because few women were included in these trials, a
decrease in AAA-related mortality or incidence of
rupture could not be identiÔ¨Åed.5 Although AAA prevalence is lower in women, the rate of rupture and overall
life expectancy are higher, which suggest that screening
may be more cost-effective in women.252
In 2005, the U.S. Preventive Services Task